Alembic Pharma announces U.S. FDA approval for Dabigatran Etexilate Capsules, 75 mg and 150 mg and tentative approval for Dabigatran Etexilate Capsules, 110 mg Read more
Alembic Pharmaceuticals announces US FDA tentative approval for Dabigatran Etexilate capsules Read more